With a focus on prevention, we're developing a range of clinically validated therapeutic products that modify the way we age.
Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine
Biotech company Morphoceuticals has announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence. Seed funding will advance programs using electroceuticals in limb regeneration and...